• Robust Quality Systems that continuously evolve and improve to conform to current Good Manufacturing Practices, industry regulations and guidances.
  • Commitment to providing quality products and service to meet the client's needs
  • Effective communication and shared responsibility with the client ensures quality at every stage of the project
  • Regulatory compliance and development support from pre-clinical to registration and commercialization
  • We assist clients through preparation of:
    • Drug Master Files (DMFs)
    • CMC sections for Investigational New Drug Applications (INDs)
    • New Drug Applications (NDAs)
    • European filings

  • FDA Inspection History
  • Pre-approval Inspection
    • May 2002 - Greenville
  • General Inspections
    • June 2004 - Greenville*
    • May 2006 - Greenville*
    • June 2006 - Florence*
    • March 2008 - Greenville*
    • June 2009 - Florence*
    • March 2011 - Greenville*
* No 483 issued
 
  Our Vision| Company Profile| Capabilities| API Activity